A comparison of patient-reported outcomes between Alloderm and Dermacell in immediate alloplastic breast reconstruction: a randomized control trial
MJ Stein, A Arnaout, JB Lichtenstein, SG Frank… - Journal of Plastic …, 2021 - Elsevier
Summary Background Alloderm and Dermacell are the two leading human acellular dermal
matrices (ADM) in immediate breast reconstruction (IBR). Despite differences in sterility,
consistency, thickness and cost, there are no comparative trials to date to compare patient-
reported outcome measures (PROM) between the two products. The purpose of this study
was to determine if there was a difference in patient-reported outcomes (as measured by the
BREAST-Q) between patients reconstructed with Alloderm and Dermacell. Methods A single …
matrices (ADM) in immediate breast reconstruction (IBR). Despite differences in sterility,
consistency, thickness and cost, there are no comparative trials to date to compare patient-
reported outcome measures (PROM) between the two products. The purpose of this study
was to determine if there was a difference in patient-reported outcomes (as measured by the
BREAST-Q) between patients reconstructed with Alloderm and Dermacell. Methods A single …
以上显示的是最相近的搜索结果。 查看全部搜索结果